Current Advances in Aortic Valve Stenosis
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 2849
Special Issue Editor
Special Issue Information
Dear Colleagues,
The prevalence of aortic stenosis (AS) in the community is an issue of great interest. It is expected that the burden of AS will increase because of the ageing population, and the prevalence will have doubled by 2050. The development of 3/4D reconstruction imaging assessments has bought about further possibilities with a high diagnostic ability. The progress of a minimally invasive and transcutaneous management approach in the era of structural heart diseases is remarkable. Various vavulopathies (such as aortic stenosis, mitral regurgitation or tricuspid valve regurgitation, etc.), which were previously untreatable due to high surgical risk, can now be treated. Based on the results of well-organized randomized control trials, transcutaneous aortic valve replacement (TAVI) has shown itself to be comparable to surgery results in terms of outcome and mortality, and, as a consequence, the therapeutic indications of TAVI have expanded from high and inoperable risk patients to intermediate and even lately to lower risk patients. However, despite technological progress being made and increased operator expertise, there are still issues that remain to be discussed. In this Special Issue, we invite authors to submit papers focused on the clinical advancements of AS in terms of long-term management.
Dr. Antonios Halapas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- valvular heart diseases
- aortic stenosis
- prevention
- diagnosis
- management
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
